SARS-CoV-2 (COVID-19) vaccine 2026-2027, mRNA-BNT162b2 XFG (JN.1) 0.3 mL Prefilled Syringe, 12y+
RxNorm 2751894
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2751894 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: SARS-CoV-2 (COVID-19) vaccine 2026-2027, mRNA-BNT162b2 XFG (JN.1) 0.3 mL Prefilled Syringe, 12y+.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
0.3 mL SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 XFG (JN.1) 0.1 mg/ML Prefilled Syringe
(Atom ID: 13082593)
PSNPrescribable
Prescribable Name (PSN):
SARS-CoV-2 (COVID-19) vaccine 2026-2027, mRNA-BNT162b2 XFG (JN.1) 0.3 mL Prefilled Syringe, 12y+
(Atom ID: 13082605)
SYPrescribable